GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Walgreens Boots Alliance Inc (LTS:0LSZ) » Definitions » Debt-to-EBITDA

Walgreens Boots Alliance (LTS:0LSZ) Debt-to-EBITDA : -0.68 (As of Feb. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Walgreens Boots Alliance Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Walgreens Boots Alliance's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Feb. 2024 was $4,276 Mil. Walgreens Boots Alliance's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Feb. 2024 was $29,347 Mil. Walgreens Boots Alliance's annualized EBITDA for the quarter that ended in Feb. 2024 was $-49,448 Mil. Walgreens Boots Alliance's annualized Debt-to-EBITDA for the quarter that ended in Feb. 2024 was -0.68.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Walgreens Boots Alliance's Debt-to-EBITDA or its related term are showing as below:

LTS:0LSZ' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -12.99   Med: 2.13   Max: 13.26
Current: -2.99

During the past 13 years, the highest Debt-to-EBITDA Ratio of Walgreens Boots Alliance was 13.26. The lowest was -12.99. And the median was 2.13.

LTS:0LSZ's Debt-to-EBITDA is ranked worse than
100% of 419 companies
in the Healthcare Providers & Services industry
Industry Median: 2.57 vs LTS:0LSZ: -2.99

Walgreens Boots Alliance Debt-to-EBITDA Historical Data

The historical data trend for Walgreens Boots Alliance's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Walgreens Boots Alliance Debt-to-EBITDA Chart

Walgreens Boots Alliance Annual Data
Trend Aug14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.39 13.26 6.85 5.57 -12.99

Walgreens Boots Alliance Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.18 23.48 21.78 23.63 -0.68

Competitive Comparison of Walgreens Boots Alliance's Debt-to-EBITDA

For the Pharmaceutical Retailers subindustry, Walgreens Boots Alliance's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Walgreens Boots Alliance's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Walgreens Boots Alliance's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Walgreens Boots Alliance's Debt-to-EBITDA falls into.



Walgreens Boots Alliance Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Walgreens Boots Alliance's Debt-to-EBITDA for the fiscal year that ended in Aug. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(3265 + 30269) / -2582
=-12.99

Walgreens Boots Alliance's annualized Debt-to-EBITDA for the quarter that ended in Feb. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(4276 + 29347) / -49448
=-0.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Feb. 2024) EBITDA data.


Walgreens Boots Alliance  (LTS:0LSZ) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Walgreens Boots Alliance Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Walgreens Boots Alliance's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Walgreens Boots Alliance (LTS:0LSZ) Business Description

Address
108 Wilmot Road, Deerfield, IL, USA, 60015
Walgreens Boots Alliance is one of the largest retail pharmacy chains in the U.S., with over 8,500 locations. Nearly three quarters of Americans live within five miles of a Walgreens location. Roughly two thirds of revenue is generated from prescription drug sales; Walgreens makes up 20% of total prescription revenue in the U.S. Walgreens also generates sales from retail products (general wellness consumables and its own branded merchandise), European drug wholesale, and healthcare. With more locations incorporating additional services like Health Corner and Village Medical, Walgreens creates an omnichannel experience for patients and positions itself as a one-stop healthcare provider.

Walgreens Boots Alliance (LTS:0LSZ) Headlines

No Headlines